A Polymeric Bioresorbable Vascular Scaffold Versus an Everolimus-Eluting Stent in ST-Segment Elevation Myocardial Infarction.
Bioresorbable vascular scaffold (BRS) devices deliver both short-term coronary artery support and drugs. This could potentially be advantageous in patients suffering from STEMI featuring large and necrotic thrombus-rich lesions, which are often associated with stent-related complications. We performed a meta-analysis comparing polymeric BRS vs everolimus-eluting stent in STEMI patients.